Gary is Managing Director in the Life Sciences Group at Safeguard Scientifics, Inc. (www.safeguard.com) (NYSE: SFE), a provider of growth capital for entrepreneurial and innovative life sciences and technology companies, where he is responsible for identifying and partnering with companies focused on molecular diagnostics, medical devices, regenerative medicine and specialty pharmaceuticals services. As part of Safeguard’s Life Sciences Group, Gary brings more than 17 years of experience in operations and investments, leveraging his expertise to enable businesses to grow their products and services, as well as to discover new partnering potential. Dr. Kurtzman currently serves on the board of directors for Safeguard Scientifics’ partner companies: Advanced BioHealing, Alverix, Avid Radiopharmaceutics, Molecular Biometrics, NuPathe and Tengion. Gary was previously managing director of BioAdvance, an early stage life sciences investor, and held various positions at Pluvita Corporation, Genovo and Avigen, and Gilead Sciences.

 

Gary is a board-certified internist with a hematology sub-specialty. He is the author of more than 40 peer reviewed scientific publications, reviews and book chapters and the inventor on 18 issued U.S. patents. He is currently a lecturer in Health Care Management at The Wharton School of the University of Pennsylvania where he teaches bioentrepreneurship. Gary received his BS from Stanford University and his MD from Washington University and post-doctoral training at the National Heart, Lung and Blood Institute and Stanford University.